Quest Diagnostics
811 hedge funds and large institutions have $14B invested in Quest Diagnostics in 2020 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 290 increasing their positions, 261 reducing their positions, and 65 closing their positions.
250% more funds holding in top 10
Funds holding in top 10: 2 → 7 (+5)
100% more first-time investments, than exits
New positions opened: 130 | Existing positions closed: 65
21% more call options, than puts
Call options by funds: $77.5M | Put options by funds: $64.3M
11% more repeat investments, than reductions
Existing positions increased: 290 | Existing positions reduced: 261
7% more funds holding
Funds holding: 757 → 811 (+54)
5% more capital invested
Capital invested by funds: $13.4B → $14B (+$632M)
0.93% less ownership
Funds ownership: 87.62% → 86.69% (-0.93%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$68.5M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$52.8M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$47.6M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$47.6M |
| 5 |
Morgan Stanley
New York
|
+$39.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$228M |
| 2 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$99.8M |
| 3 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$74.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$69M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$51.4M |
DGX Hedge Fund Activity: Q4 2020 in Review
811 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2020, worth a combined $14B — up 4.7% from $13.4B a quarter earlier.
Buyers outnumbered sellers: 130 funds opened new DGX positions and 65 closed out — a net gain of 65 holders — while 290 added to existing stakes and 261 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $68.5M. The largest seller was Ameriprise, cutting an estimated $228M.
- 811 institutional investors held Quest Diagnostics (DGX) as of Q4 2020, up from 757 in Q3 2020.
- Funds reported $14B of Quest Diagnostics stock for Q4 2020, up 4.7% quarter-over-quarter.
- 130 funds opened new Quest Diagnostics positions in Q4 2020 and 65 closed out, a net change of +65 holders.
- The largest Quest Diagnostics buyer in Q4 2020 was Renaissance Technologies, an estimated $68.5M added.
- The largest Quest Diagnostics seller in Q4 2020 was Ameriprise, an estimated $228M sold.
Based on aggregated 13F filings for Q4 2020.